Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O6AQ
|
||||
Former ID |
DNC000678
|
||||
Drug Name |
Gavestinel
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nerve injury [ICD10:T14.4] | Discontinued in Phase 2 | [546403] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H12Cl2N2O3
|
||||
Canonical SMILES |
C1=CC=C(C=C1)NC(=O)C=CC2=C(NC3=CC(=CC(=C32)Cl)Cl)C(=O)O
|
||||
InChI |
1S/C18H12Cl2N2O3/c19-10-8-13(20)16-12(17(18(24)25)22-14(16)9-10)6-7-15(23)21-11-4-2-1-3-5-11/h1-9,22H,(H,21,23)(H,24,25)/b7-6+
|
||||
InChIKey |
WZBNEZWCNKUOSM-VOTSOKGWSA-N
|
||||
CAS Number |
CAS 153436-22-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glycine receptor | Target Info | Modulator | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Reactome | Ligand-gated ion channel transport | ||||
WikiPathways | Iron uptake and transport | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.